Literature DB >> 17004353

Use of steroids for self-enhancement: an epidemiologic/societal perspective.

C E Yesalis1.   

Abstract

Humans are basically competitive. For centuries, athletes have used various substances to enhance performance, increase strength, and prolong endurance. In the early 1940s, research indicating that testosterone improved a sense of well-being, appearance, and sexual performance led to the use of anabolic steroid hormones by a select few athletes. Today, even among high school students, the use of androgenic steroid hormones is prevalent, with 1% to 2% of adolescent girls and 4% to 6% of adolescent boys having used an anabolic steroid at least once. An estimated 1 million people in the United States are current of former users of anabolic-androgenic steroid hormones, with men having a higher prevalence of use than women. Androgenic steroid use has been associated with the use of other illicit drugs, cigarette smoking, and alcohol use. Nevertheless, anabolic-androgenic steroid hormones appear to have legitimate uses in certain patients. In HIV-infected, hypogonadal men, anabolic steroid hormones optimize muscle strength and muscle mass when combined with resistance exercise. Although a large number of people have used these drugs for many years, no studies of the long-term health effects have been done. However, when taken in supraphysiologic doses, these drugs are known to cause a wide range of acute adverse effects. When used in less then supraphysiologic doses in eugonadal or hypogonadal HIV-infected patients, these drugs reverse HIV-related hypogonadism, muscle wasting, and perhaps lipodystrophy. Provided that the oral preparations are not used and patients are closely monitored, anabolic-androgenic steroid hormones offer HIV-infected patients a better quality of life and an improved sense of well-being.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 17004353

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  5 in total

1.  [Cardiovascular alterations associated with doping].

Authors:  D Thieme; A Büttner
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

2.  Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass.

Authors:  Stephanie T Page; Brett T Marck; James M Tolliver; Alvin M Matsumoto
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

3.  Global gene expression of fission yeast in response to cisplatin.

Authors:  L Gatti; D Chen; G L Beretta; G Rustici; N Carenini; E Corna; D Colangelo; F Zunino; J Bähler; P Perego
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

4.  The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia).

Authors:  Mosleh Jabari; Hassan Al-Shehri; Abdullah Al-Faris; Mohammed Al-Sayed; Fahd Algaeed; Nasser Al-Sobaie; Fawaz Al-Saleh
Journal:  Electron Physician       Date:  2016-12-25

5.  Physical and cognitive doping in university students using the unrelated question model (UQM): Assessing the influence of the probability of receiving the sensitive question on prevalence estimation.

Authors:  Pavel Dietz; Anne Quermann; Mireille Nicoline Maria van Poppel; Heiko Striegel; Hannes Schröter; Rolf Ulrich; Perikles Simon
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.